News
Public · Published
NRC Health Announces Third Quarter 2026 Results
NRC Health reported third quarter 2026 revenue of $38.4 million, up 11% from a year earlier. Net income was $4.7 million, or 12% of revenue, and earnings per share were $0.21. A large customer went live on schedule, and several long-standing customers renewed multi-year agreements.
Published:
Updated:
What happened
NRC Health reported third quarter 2026 revenue of $38.4 million, up 11% from a year earlier. Net income was $4.7 million, or 12% of revenue, and earnings per share were $0.21. A large customer went live on schedule, and several long-standing customers renewed multi-year agreements.
Confirmed
Global impact / market context
Renewed multi-year contracts and a large customer going live turn the contract base into recurring revenue, which gives the company more predictable cash coming in. Management expects that growing revenue base to spread fixed costs, lifting profit and free cash flow, which means cash left after spending on operations and equipment.
Analyst inference
Investors in healthcare software and services companies watch recurring contract value and customer renewals because they signal how durable future revenue is. Here, recurring contract value of $154.1 million, up 9%, grew more slowly than the 11% revenue growth, so the mix of contract growth versus recorded revenue is a key signal.
Analyst inference
What to watch
- Total recurring contract value was $154.1 million, up 9% year-over-year, which is the value of signed recurring contracts. Watch whether this grows faster than revenue, since it feeds future reported sales. Confirmed
- Management said it expects the expanding contract base to convert into revenue and produce greater profitability and free cash flow over time. Watch whether coming quarters show that conversion in reported revenue, profit and cash. Proposed
- Watch customer retention and new contract signings, because several multi-year renewals supported this quarter's results. Slower renewals or fewer new deals could reduce recurring revenue and pressure profit, since fixed costs stay largely unchanged. Analyst inference
Evidence
- Original source link unavailable